Ctl inducer composition

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01) C07K 7/06 (2006.01)

Patent

CA 2697896

The present invention provides a CTL inducer composition which comprises one or more peptides selected from the group consisting of the peptides of SEQ ID NOS: 1 to 27 in the Sequence Listing, and can be used for the treatment or prevention of cancer or a hepatitis C virus-related disease in two or more patient groups selected from the group consisting of an HLA-A2 positive patient group, an HLA-A24 positive patient group, an HLA-A26 positive patient group, and an HLA-A3 supertype positive patient group.

L'invention porte sur une composition inductrice de lymphocytes T cytotoxiques (CTL), laquelle composition contient au moins un peptide choisi dans le groupe constitué par les peptides représentés par les séquences n°1 à n°27 dans la section = listage des séquences =, et peut être utilisée pour le traitement ou la prévention d'un cancer ou d'une maladie associée au virus de l'hépatite C dans au moins deux groupes de patients choisis dans l'ensemble constitué par un groupe de patients positifs au HLA-A2, un groupe de patients positifs au HLA-A24, un groupe de patients positifs au HLA-A26 et un groupe de patients positifs au supertype HLA-A3.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ctl inducer composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ctl inducer composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ctl inducer composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1909687

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.